A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma

Grant

Awarded By

Total Award Amount

  • 1604566.00

    • Direct Costs

  • 1158966.00

    • Sponsor Award Id

  • R01CA217179

    • Contributor

  • Anita Hjelmeland Ph.D.   Investigator  
  • C. Ryan Miller   Investigator  
  • Caitlin Dalgo MSN, BSN, RN, MSN, CRNP, AGACNP-BC, RNFA   Investigator  
  • Gary Cutter   Investigator  
  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Inmaculada Aban   Investigator  
  • James Markert M.D., M.P.H.   Principal Investigator  
  • Jianmei Leavenworth Ph.D.   Investigator  
  • Kristen Riley   Investigator  
  • Lawrence Lamb Jr. Ph.D.   Investigator  
  • Louis Nabors M.D.   Investigator  
  • Philip Schmalz   Investigator  
  • Xiaosi Han   Investigator